Pillar Point antitrust complaint readied by FTC investigators, Summit says.
This article was originally published in The Gray Sheet
Executive SummaryPILLAR POINT ANTITRUST COMPLAINT READIED BY FTC INVESTIGATORS, Pillar Point partner Summit Technology discloses in its second quarter financial report. Federal Trade Commission investigators have "reason to believe that a violation of the Federal Trade Commission Act may have occurred and that [they are] prepared to recommend that the Commission issue an administrative complaint under the act," Summit says.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.